UK Bioscience Gets $62M to Bridge Valley of Death
Twenty-two UK life sciences companies and a further 10 academic groups will share £39 million (US$62.3 million) in research funding in the largest grant allocation that the Biomedical Catalyst scheme has made to date.
The initiative, which will provide £180 million to accelerate UK life sciences projects over three years, is administered jointly by the Technology Strategy Board (TSB), the UK's innovation agency, and the Medical Research Council.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST